相关实验视频

Updated: Sep 12, 2025

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Published on: November 22, 2021

在小细胞肺癌治疗中对onvansertib进行单细胞转录和药理学研究

Hyeon Do Jeon¹, Insung Choi², Woojeung Song³

¹Department of Precision Medicine, College of Medicine, Kyung Hee University, Seoul 02447, South Korea.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

|August 9, 2025

概括

通过阻止细胞循环,Onvansertib有效地抑制小细胞肺癌 (SCLC) 的生长. 然而,毒性需要探索组合疗法或降低剂量的安全和有效的癌症治疗.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
药理学药理学是指药理学的学科.

背景情况:

波罗样酶1 (PLK1) 对于细胞分裂至关重要,其失调驱动癌症.
像onvansertib一样的PLK1抑制剂正在作为抗癌剂进行研究.
昂凡塞蒂布正在进行针对复发小细胞肺癌 (SCLC) 的II期试验.

研究的目的:

在SCLC中全面描述onvansertib的疗效,耐受性和毒性.
阐明在SCLC中使用onvansertib的药理机制.
为优化onvansertib治疗策略提供证据.

主要方法:

在144个癌症细胞系进行体外查.
使用SCLC异种移植小鼠模型进行体内疗效和毒性研究.
单细胞RNA测序用于机械洞察力.

主要成果:

在SCLC细胞系中,对onvansertib的反应性很高.
与间歇剂量相比,每日口服onvansertib (60 mg/kg) 显示出优异的瘤回归.
在60mg/kg剂量时观察到显著的体内毒性,包括死亡率和血液学影响.
通过降低细胞分裂过程的调节,Onvansertib会诱导G2/M阶段停止.

结论:

昂凡塞蒂布表现出强大的抗SCLC活性,但由于毒性,需要谨慎的剂量管理.
这些发现支持组合疗法或低剂量疗法用于临床应用.
机制研究揭示了onvansertib在细胞循环调节中的作用.

关键词:

癌症治疗方法癌症治疗方法在Vansertib上药理学概况药理学概况波罗类类型的激酶1抑制剂单细胞RNA测序的测序方法小细胞肺癌是一种小细胞肺癌.

更多相关视频

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Published on: April 3, 2018

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...